obstructive jaundice |
Disease ID | 1283 |
---|---|
Disease | obstructive jaundice |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:9) C0009450 | infection | 5 C0854776 | unresectable pancreatic cancer | 3 C0863194 | resectable hepatocellular carcinoma | 2 C1335316 | serous cystadenoma of the pancreas | 1 C0018994 | hemobilia | 1 C0035078 | renal failure | 1 C0021079 | immunosuppression | 1 C0162429 | malnutrition | 1 C0022660 | acute renal failure | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:30) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0022354 | aminoglutethimide | D000616 | 125-84-8 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 6691647 | ||
C0022354 | amitriptyline | D000639 | 50-48-6 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 11092117 | ||
C0022354 | busulfan | D002066 | 55-98-1 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 5278972 | ||
C0022354 | carbimazole | D002231 | 22232-54-8 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 3968675 | ||
C0022354 | chlorpromazine | D002746 | 50-53-3 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 14961937 | ||
C0022354 | ciprofloxacin | D002939 | 85721-33-1 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 12399240 | ||
C0022354 | clozapine | D003024 | 5786-21-0 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 2773535 | ||
C0022354 | disopyramide | D004206 | 3737/9/5 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 6834895 | ||
C0022354 | enalapril | D004656 | 75847-73-3 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 2342045 | ||
C0022354 | ethambutol | D004977 | 74-55-5 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 3083914 | ||
C0022354 | floxuridine | D005467 | 50-91-9 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 2848277 | ||
C0022354 | fosinopril | D017328 | 98048-97-6 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 11293449 | ||
C0022354 | griseofulvin | D006118 | 126-07-8 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 131731 | ||
C0022354 | imipramine | D007099 | 50-49-7 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 7429116 | ||
C0022354 | lactulose | D007792 | 4618-18-2 | jaundice, obstructive | MESH:D041781 | therapeutic | 2311978 | ||
C0022354 | lovastatin | D008148 | 75330-75-5 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 2026107 | ||
C0022354 | medroxyprogesterone acetate | D017258 | 71-58-9 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 23956101 | ||
C0022354 | metformin | D008687 | 657-24-9 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 11467664 | ||
C0022354 | octreotide | D015282 | 83150-76-9 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 10923237 | ||
C0022354 | phenytoin | D010672 | 57-41-0 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 6721716 | ||
C0022354 | piroxicam | D010894 | 36322-90-4 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 1955140 | ||
C0022354 | propylthiouracil | D011441 | 51-52-5 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 3528517 | ||
C0022354 | rifampin | D012293 | 13292-46-1 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 2488482 | ||
C0022354 | sulindac | D013467 | 38194-50-2 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 7083082 | ||
C0022354 | sulpiride | D013469 | 15676-16-1 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 3326861 | ||
C0022354 | tacrolimus | D016559 | 109581-93-3 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 18648179 | ||
C0022354 | tenoxicam | C032801 | 59804-37-4 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 12821054 | ||
C0022354 | ticlopidine | D013988 | 55142-85-3 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 1834400 | ||
C0022354 | trimethoprim | D014295 | 738-70-5 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 1937651 | ||
C0022354 | valproic acid | D014635 | 99-66-1 | jaundice, obstructive | MESH:D041781 | marker/mechanism | 3110488 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |